We work across the oncology ecosystem — not just one corner of it.
Our Oncology Domain Expertise
Cancer Types
Breast
Early, advanced, metastatic, HER2+, HR+/HER2-, TNBC, etc.
NSCLC
Early, advanced, metastatic, SCLC, EGFR, ALK, KRAS, etc.
Prostate
Early, locally advanced, metastatic, etc.
Liver
HCC, early stage, unresectable, advanced, metastatic.
Pan-cancer
Solid and blood cancers, supportive care needs across >20 types.
And more
CRC, cervical, thyroid, ovarian, MM, NHL, CLL, amongst others.
Focus Areas
Detect
CED, Liquid Biopsy, AI Screening, Molecular Imaging, Digital Pathology
Diagnose
NGS, Tissue biopsy, Companion Dx, Spatial biology, Proteomics
Stratify
Biomarkers, Genomic Profiling, MRD, AI decision Support, Tumor Boards
Treat
Targeted, Immunotherapy, CAR-T, ADCs, Radioligand, mRNA vaccines
Interventions
Radiotherapy, Image Guided Therapies, Lasers, Ablation
Monitor
ctDNA, MRD, Remote Monitoring, AI imaging, Recurrence prediction
Our Oncology Research Experience
Experience by Project Type
25% Market Opportunity (TPP/Demand)
20% Value Proposition/Positioning
20% Concept & Message Testing
30% ATU (Chart Audit)/Brand Equity
5% Others
Methodology used across these studies
Qualitative
65%
Quantitative
70%
Our Research Reach
Total HCP Panel
4Mn+
10,000+
Oncology Experts Panel
38% Medical Oncologists
13% Surgical Oncologists
9% Radiation Oncologists
15% Hematology Oncologists
25% Others
Global Reach. Local Expertise.
Meet the Oncology Team
Here's to the next decade of supporting oncology innovation.